GSK and Vir Biotechnology announce submission of Emergency Use Authorization request to FDA for VIR-7831 for the early treatment of COVID-19

For media and investors onlyIssued: London, UK and San Francisco, USGlaxoSmithKline plc and Vir Biotechnology, Inc. today announced the submission of an application to the U.S. Food and... Read More